These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30010736)

  • 1. Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis.
    Estevinho MM; Afonso J; Rosa I; Lago P; Trindade E; Correia L; Dias CC; Magro F;
    J Crohns Colitis; 2018 Nov; 12(10):1232-1244. PubMed ID: 30010736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Literature Review: Ability of the IBDQ-32 to Detect Meaningful Change in Ulcerative Colitis Health Indicators.
    Dubinsky M; Rice A; Yarlas A; Hur P; Cappelleri JC; Kulisek N; Fahrny A; Bushmakin A; Biedermann L
    Inflamm Bowel Dis; 2023 Dec; ():. PubMed ID: 38150386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12.
    Armuzzi A; Rubin DT; Schreiber S; Panés J; Fellmann M; Bartolome L; Gruben D; Goetsch M; Bhattacharjee A; Chaparro M; Dubinsky MC
    Inflamm Bowel Dis; 2024 Sep; ():. PubMed ID: 39326009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in patients with inflammatory bowel disease: a single-center experience.
    Kalafateli M; Triantos C; Theocharis G; Giannakopoulou D; Koutroumpakis E; Chronis A; Sapountzis A; Margaritis V; Thomopoulos K; Nikolopoulou V
    Ann Gastroenterol; 2013; 26(3):243-248. PubMed ID: 24714279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quality of life assessment in Inflammatory Bowel Disease (IBD): German version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; disease-specific instrument for quality of life assessment) -- first application and comparison with international investigations].
    Janke KH; Steder-Neukamm U; Bauer M; Raible A; Meisner C; Hoffmann JC; Gregor M; Klump B; Häuser W
    Gesundheitswesen; 2005; 67(8-9):656-64. PubMed ID: 16217720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Ustekinumab on Health-related Quality of Life in Patients With Moderate to Severe Crohn's Disease.
    Sands BE; Han C; Gasink C; Jacobstein D; Szapary P; Gao LL; Lang Y; Targan S; Sandborn WJ; Feagan BG
    J Crohns Colitis; 2018 Jul; 12(8):883-895. PubMed ID: 29726939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of patients' understanding of inflammatory bowel diseases: Development and validation of a questionnaire.
    Ostromohov G; Fibelman M; Hirsch A; Ron Y; Cohen NA; Kariv R; Deutsch L; Kornblum J; Anbar R; Maharshak N; Fliss-Isakov N
    United European Gastroenterol J; 2022 Feb; 10(1):104-114. PubMed ID: 34939350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically meaningful improvement in health-related quality of life in a randomized controlled trial of certolizumab pegol maintenance therapy for Crohn's disease.
    Feagan BG; Coteur G; Tan S; Keininger DL; Schreiber S
    Am J Gastroenterol; 2009 Aug; 104(8):1976-83. PubMed ID: 19471252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease.
    Park SK; Ko BM; Goong HJ; Seo JY; Lee SH; Baek HL; Lee MS; Park DI
    World J Gastroenterol; 2017 May; 23(19):3530-3537. PubMed ID: 28596689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in inflammatory bowel disease: a comparison of patients receiving nurse-led versus conventional follow-up care.
    Alvestad L; Jelsness-Jørgensen LP; Goll R; Clancy A; Gressnes T; Valle PC; Broderstad AR
    BMC Health Serv Res; 2022 Dec; 22(1):1602. PubMed ID: 36587197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease.
    Bernklev T; Jahnsen J; Henriksen M; Lygren I; Aadland E; Sauar J; Schulz T; Stray N; Vatn M; Moum B
    Inflamm Bowel Dis; 2006 May; 12(5):402-12. PubMed ID: 16670530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort.
    Romberg-Camps MJ; Bol Y; Dagnelie PC; Hesselink-van de Kruijs MA; Kester AD; Engels LG; van Deursen C; Hameeteman WH; Pierik M; Wolters F; Russel MG; Stockbrügger RW
    Inflamm Bowel Dis; 2010 Dec; 16(12):2137-47. PubMed ID: 20848468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Paramsothy S; Paramsothy R; Rubin DT; Kamm MA; Kaakoush NO; Mitchell HM; Castaño-Rodríguez N
    J Crohns Colitis; 2017 Oct; 11(10):1180-1199. PubMed ID: 28486648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn's disease and intestinal Behçet's disease.
    Kim WH; Cho YS; Yoo HM; Park IS; Park EC; Lim JG
    Int J Colorectal Dis; 1999 Feb; 14(1):52-7. PubMed ID: 10207731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of probiotics in the induction and maintenance of inflammatory bowel disease remission: a systematic review and meta-analysis.
    Chen M; Feng Y; Liu W
    Ann Palliat Med; 2021 Nov; 10(11):11821-11829. PubMed ID: 34872306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shortened questionnaire on quality of life for inflammatory bowel disease.
    Alcalá MJ; Casellas F; Fontanet G; Prieto L; Malagelada JR
    Inflamm Bowel Dis; 2004 Jul; 10(4):383-91. PubMed ID: 15475746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the health-related questionnaire IBDQ-32 in Mexican patients with inflammatory bowel disease.
    Zavala-Solares MR; Salazar-Salas L; Yamamoto-Furusho JK
    Gastroenterol Hepatol; 2021 Dec; 44(10):711-718. PubMed ID: 33872624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in patients with inflammatory bowel disease: a Tunisian study.
    Mnif L; Mzid A; Amouri A; Chtourou L; Tahri N
    Tunis Med; 2010 Dec; 88(12):933-6. PubMed ID: 21136364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials.
    Peyrin-Biroulet L; Ghosh S; Lee SD; Lee WJ; Griffith J; Wallace K; Berg S; Liao X; Panes J; Loftus EV; Louis E
    Aliment Pharmacol Ther; 2023 Mar; 57(5):496-508. PubMed ID: 36266762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.